Correlation Between Apogee Therapeutics, and 907818GF9

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Apogee Therapeutics, and 907818GF9 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apogee Therapeutics, and 907818GF9 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apogee Therapeutics, Common and UNP 495 15 MAY 53, you can compare the effects of market volatilities on Apogee Therapeutics, and 907818GF9 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apogee Therapeutics, with a short position of 907818GF9. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apogee Therapeutics, and 907818GF9.

Diversification Opportunities for Apogee Therapeutics, and 907818GF9

0.7
  Correlation Coefficient

Poor diversification

The 3 months correlation between Apogee and 907818GF9 is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Apogee Therapeutics, Common and UNP 495 15 MAY 53 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on UNP 495 15 and Apogee Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apogee Therapeutics, Common are associated (or correlated) with 907818GF9. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of UNP 495 15 has no effect on the direction of Apogee Therapeutics, i.e., Apogee Therapeutics, and 907818GF9 go up and down completely randomly.

Pair Corralation between Apogee Therapeutics, and 907818GF9

Given the investment horizon of 90 days Apogee Therapeutics, Common is expected to generate 3.63 times more return on investment than 907818GF9. However, Apogee Therapeutics, is 3.63 times more volatile than UNP 495 15 MAY 53. It trades about 0.07 of its potential returns per unit of risk. UNP 495 15 MAY 53 is currently generating about 0.01 per unit of risk. If you would invest  1,700  in Apogee Therapeutics, Common on October 25, 2024 and sell it today you would earn a total of  2,192  from holding Apogee Therapeutics, Common or generate 128.94% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy94.01%
ValuesDaily Returns

Apogee Therapeutics, Common  vs.  UNP 495 15 MAY 53

 Performance 
       Timeline  
Apogee Therapeutics, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Apogee Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
UNP 495 15 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in UNP 495 15 MAY 53 are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, 907818GF9 may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Apogee Therapeutics, and 907818GF9 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Apogee Therapeutics, and 907818GF9

The main advantage of trading using opposite Apogee Therapeutics, and 907818GF9 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apogee Therapeutics, position performs unexpectedly, 907818GF9 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 907818GF9 will offset losses from the drop in 907818GF9's long position.
The idea behind Apogee Therapeutics, Common and UNP 495 15 MAY 53 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets